SYNDAX PHARMACEUTICALS INC (SNDX)

US87164F1057 - Common Stock

20.29  -0.63 (-3.01%)

After market: 20.29 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.00139.70M1.50M
Operating Expenses
263.52M229.95M151.80M113.50M72.90M
Research and Development
185.52M163.03M118.50M88.20M50.40M
Selling, General, and Administrative Expenses
78.00M66.92M33.30M25.20M22.50M
Operating Income
-263.52M-229.95M-151.80M26.20M-71.40M
Interest Income/Expense
23.19M20.95M2.70M-1.50M-1.50M
Other Income/Expense
-342.00K-361.00K-300.00K200.00K-200.00K
Income Before Taxes
-240.57M-209.36M-149.30M24.90M-73.20M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-240.57M-209.36M-149.30M24.90M-77.10M
EBITDA
N/A-229.94M-151.77M26.24M-71.31M
 
Per Share Data
EPS Diluted Total Ops
-3.22-2.98-2.460.46-1.87
Non GAAP EPS
-3.22-2.96-2.450.43-1.88
 
Statistics
Profit Margin
N/AN/AN/A17.82%-5140.00%
Operating Profit Margin
N/AN/AN/A18.75%-4760.00%

All data in USD

Charts